Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration
Purpose GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown. Methods Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hair...
Saved in:
Published in | Cellular oncology (Dordrecht) Vol. 47; no. 4; pp. 1391 - 1403 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.08.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.
Methods
Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.
Results
The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.
Conclusion
The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC. |
---|---|
AbstractList | GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.
Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.
The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.
The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC. GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.PURPOSEGPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.METHODSImmunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.RESULTSThe GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.CONCLUSIONThe findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC. Purpose GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown. Methods Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry. Results The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8. Conclusion The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC. PurposeGPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.MethodsImmunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.ResultsThe GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.ConclusionThe findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC. |
Author | Zhou, Jian Zhu, Gui-Qi Zhou, Yu-Fu Jiang, Xi-Fei Fan, Jia Liu, Wei-Ren Tang, Zheng Huang, Run Wu, Xiao-Ling Tao, Chen-Yang Chu, Tian-Hao Qu, Wei-Feng Dai, Zhi Gao, Jun Chen, Jia-Feng Shi, Ying-Hong Zhao, Qian-Fu Song, Shu-Shu Yang, Rui Fang, Yuan Tian, Meng-Xin Ding, Zhen-Bin |
Author_xml | – sequence: 1 givenname: Chen-Yang surname: Tao fullname: Tao, Chen-Yang organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 2 givenname: Xiao-Ling surname: Wu fullname: Wu, Xiao-Ling organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 3 givenname: Shu-Shu surname: Song fullname: Song, Shu-Shu organization: Department of Biochemistry and Molecular, School of Basic Medical Sciences, Fudan University – sequence: 4 givenname: Zheng surname: Tang fullname: Tang, Zheng organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 5 givenname: Yu-Fu surname: Zhou fullname: Zhou, Yu-Fu organization: Department of Immunology and Pathogenic Biology, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine – sequence: 6 givenname: Meng-Xin surname: Tian fullname: Tian, Meng-Xin organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 7 givenname: Xi-Fei surname: Jiang fullname: Jiang, Xi-Fei organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 8 givenname: Yuan surname: Fang fullname: Fang, Yuan organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 9 givenname: Gui-Qi surname: Zhu fullname: Zhu, Gui-Qi organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 10 givenname: Run surname: Huang fullname: Huang, Run organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 11 givenname: Wei-Feng surname: Qu fullname: Qu, Wei-Feng organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 12 givenname: Jun surname: Gao fullname: Gao, Jun organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 13 givenname: Tian-Hao surname: Chu fullname: Chu, Tian-Hao organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 14 givenname: Rui surname: Yang fullname: Yang, Rui organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 15 givenname: Jia-Feng surname: Chen fullname: Chen, Jia-Feng organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 16 givenname: Qian-Fu surname: Zhao fullname: Zhao, Qian-Fu organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 17 givenname: Zhen-Bin surname: Ding fullname: Ding, Zhen-Bin organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 18 givenname: Zhi surname: Dai fullname: Dai, Zhi organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 19 givenname: Jian surname: Zhou fullname: Zhou, Jian organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 20 givenname: Wei-Ren surname: Liu fullname: Liu, Wei-Ren organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 21 givenname: Ying-Hong surname: Shi fullname: Shi, Ying-Hong organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences – sequence: 22 givenname: Jia surname: Fan fullname: Fan, Jia email: fan.jia@zs-hospital.sh.cn organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38607517$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctO3DAUhq2KqkOnvEAXyBIbNml9y4nDBiFKKdJIsGglxMbyOM5glNiDnTDq2-Nh6FBY4IVt6XznP5f_M9rxwVuEvlLyjRJSfU-UC8IKwkRBSM1FsfqAdhmjtOCCw872z-QE7aV0R_IRQKGET2jCJZCqpNUuuvkRVj7axdjpwQWPQ4vPr64ldh7f2qUegrFdl4MRGx2N86HXR9j1S20GnPFh7EPEabC9tylh7Rvcu0V80vqCPra6S3bv-Z2iPz_Pfp_-KmaX5xenJ7PCCAZDvnkDppo3nEvdcEM5SLAl1HPRzk0NYAUTpmxYU0JbM0sBDFSCCMoyBSWfouON7nKc97Yx1g9Rd2oZXa_jXxW0U68j3t2qRXhQlHLGWF7eFB0-K8RwP9o0qN6l9eDa2zAmxQmXQtBKrosdvEHvwhh9ni9TNZNCUlFlav__lra9_Nt7BtgGMDGkFG27RShRa3_Vxl-V_VVP_qpVTuKbpJRhv7DxpfY7WY-Ehaf2 |
Cites_doi | 10.4252/wjsc.v12.i11.1410 10.1242/jcs.113.16.2845 10.1016/j.jmb.2010.12.039 10.1111/1759-7714.13671 10.1002/hep.22393 10.1186/s12935-020-01692-z 10.1111/j.1440-1746.2007.05040.x 10.1080/15384047.2022.2108690 10.1016/j.freeradbiomed.2014.01.018 10.7150/jca.9215 10.1016/j.cellsig.2022.110350 10.1515/hsz-2020-0286 10.1161/ATVBAHA.109.193631 10.12659/msm.921775 10.1158/0008-5472.Can-08-1573 10.3322/caac.21660 10.1073/pnas.2010275117 10.4149/neo_2011_03_239 10.1136/gutjnl-2013-304612 10.1042/BJ20050412 10.1038/nm.4409 10.1038/nrdp.2016.18 10.1016/j.pharmthera.2012.08.014 10.21037/hbsn-22-469 10.1056/NEJMra1713263 10.1038/s41392-021-00828-5 10.1093/carcin/bgu083 10.1186/s12916-019-1341-6 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 5PM |
DOI | 10.1007/s13402-024-00934-w |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2211-3436 |
EndPage | 1403 |
ExternalDocumentID | PMC11322209 38607517 10_1007_s13402_024_00934_w |
Genre | Journal Article |
GrantInformation_xml | – fundername: Shanghai Municipal Key Clinical Specialty. CAMS Innovation Fund for Medical Sciences (CIFMS) grantid: 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058 – fundername: Shanghai Municipal Science and Technology Major Project grantid: 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05 – fundername: National Key R&D Program of China grantid: 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100 – fundername: Shanghai Municipal Health Commission grantid: 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221 – fundername: Clinical Research Plan of SHDC grantid: No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007 – fundername: National Natural Science Foundation of China grantid: 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217 – fundername: National Key R&D Program of China grantid: 2018YFC1312100 – fundername: Shanghai Municipal Science and Technology Major Project grantid: 2018SHZDZX05 – fundername: Clinical Research Plan of SHDC grantid: No. SHDC2020CR5007 – fundername: Shanghai Municipal Health Commission grantid: 202040221 – fundername: National Natural Science Foundation of China grantid: 82073217 – fundername: Shanghai Municipal Key Clinical Specialty. CAMS Innovation Fund for Medical Sciences (CIFMS) grantid: 2019-I2M-5-058 |
GroupedDBID | --- -EM 06D 0R~ 0VY 203 29~ 2KG 2KM 2VQ 30V 4.4 406 408 53G 67N 8UJ 96X AAAVM AACDK AAHNG AAIAL AAJBT AAJKR AAJSJ AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAYIU AAYQN AAYTO AAYZH AAZMS ABAKF ABDBF ABDZT ABECU ABFTV ABIPD ABJNI ABJOX ABKCH ABMQK ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABXPI ACAOD ACGFS ACHSB ACKNC ACMDZ ACMLO ACOKC ACPIV ACPRK ACUHS ACULB ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETCA AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH AOCGG AXYYD BGNMA C6C CSCUP DDRTE DNIVK DPUIP EAD EAP EBD EBLON EBS EIOEI EJD EMB EMK EMOBN EPL ESBYG ESX F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 H13 HF~ HMJXF HRMNR HZ~ I0C IKXTQ IMOTQ ITM IWAJR J-C JBSCW JZLTJ KOV LLZTM M4Y NPVJJ NQJWS NU0 O9- O93 O9J P2P PT4 R9I RLLFE ROL RSV S3A S3B SBL SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 TSG TUS U2A U9L UG4 UOJIU UTJUX UZXMN VFIZW W48 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABEEZ ABFSG ACSTC AEZWR AFDZB AFGXO AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 5PM |
ID | FETCH-LOGICAL-c426t-c43d6c7bd338ad3c13686e569b4fbc966e424c5d2d56f92e166c6740412e56653 |
IEDL.DBID | U2A |
ISSN | 2211-3428 2211-3436 |
IngestDate | Thu Aug 21 18:34:54 EDT 2025 Mon Jul 21 09:54:37 EDT 2025 Fri Jul 25 09:52:43 EDT 2025 Mon Jul 21 05:40:58 EDT 2025 Tue Jul 01 04:25:03 EDT 2025 Fri Feb 21 02:38:09 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | GPX8 Hepatocellular carcinoma Hsc70 Migration Tumor stemness |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c426t-c43d6c7bd338ad3c13686e569b4fbc966e424c5d2d56f92e166c6740412e56653 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://link.springer.com/10.1007/s13402-024-00934-w |
PMID | 38607517 |
PQID | 3092848147 |
PQPubID | 2044311 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11322209 proquest_miscellaneous_3038441785 proquest_journals_3092848147 pubmed_primary_38607517 crossref_primary_10_1007_s13402_024_00934_w springer_journals_10_1007_s13402_024_00934_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-08-01 |
PublicationDateYYYYMMDD | 2024-08-01 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
PublicationTitle | Cellular oncology (Dordrecht) |
PublicationTitleAbbrev | Cell Oncol |
PublicationTitleAlternate | Cell Oncol (Dordr) |
PublicationYear | 2024 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | Khatib, Solaimuthu, Ben Yosef, Abu Rmaileh, Tanna, Oren, Schlesinger Frisch, Axelrod, Lichtenstein, Shaul (CR8) 2020; 117 Peng, Hu, Soutto, Belkhiri, El-Rifai (CR18) 2014; 5 He, Sun, Zhang, Yang, Chen, Xu, Li (CR25) 2021; 6 Villanueva (CR3) 2019; 380 Shiota, Kusakabe, Izumi, Hikita, Nakao, Funae, Miura, Iwao (CR16) 2010; 30 CR17 CR14 Paik, Jung, Heo, Choi, Choi, Kim (CR15) 2008; 23 Ahn, Kim, Yoon, Vacratsis (CR28) 2005; 392 Chen, Xu, Shan, Chen, Hu (CR11) 2020; 20 Zhang, Liu, Guo, Zhao (CR9) 2020; 11 Batlle, Clevers (CR5) 2017; 23 Xie, Zhu, Ren, Zhou, Fan, Gao (CR2) 2023; 12 Dastoor, Dreyer (CR27) 2000; 113 Buday, Conrad (CR21) 2021; 402 Wang, Meng, Sun, Liu, Han, Du, Song, Xu (CR22) 2011; 58 Zhang, Zhan, Li, Wang, Cheng, Yao, Jia (CR20) 2020; 26 Ramming, Hansen, Nagata, Ellgaard, Appenzeller-Herzog (CR7) 2014; 70 Peng, Hu, Soutto, Belkhiri, Zaika, El-Rifai (CR19) 2014; 63 Fleming-de-moraes, Rocha, Tessmann, de Araujo, Morgado-Diaz (CR24) 2022; 23 Ding, Shi, Zhou, Qiu, Xu, Dai, Shi, Wang, Ke, Wu, Fan (CR13) 2008; 68 Daisy Precilla, Biswas, Kuduvalli, Anitha (CR23) 2022; 95 Llovet, Zucman-Rossi, Pikarsky, Sangro, Schwartz, Sherman, Gores (CR4) 2016; 2 Liu, Daniels, Cao (CR26) 2012; 136 Jagust, Alcalá, Sainz, Heeschen, Sancho (CR10) 2020; 12 Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal, Bray (CR1) 2021; 71 Shi, Ding, Zhou, He, Xu, Gambotto, Rabinowich, Fan, Yin (CR12) 2008; 48 Nguyen, Saaranen, Karala, Lappi, Wang, Raykhel, Alanen, Salo, Wang, Ruddock (CR6) 2011; 406 934_CR14 X. Zhang (934_CR20) 2020; 26 T. Liu (934_CR26) 2012; 136 Z.B. Ding (934_CR13) 2008; 68 K. Buday (934_CR21) 2021; 402 D. Peng (934_CR19) 2014; 63 Y.H. Shi (934_CR12) 2008; 48 V.D. Nguyen (934_CR6) 2011; 406 934_CR17 D.Y. Xie (934_CR2) 2023; 12 J.M. Llovet (934_CR4) 2016; 2 A. Khatib (934_CR8) 2020; 117 A. Villanueva (934_CR3) 2019; 380 X.H. Wang (934_CR22) 2011; 58 J. Zhang (934_CR9) 2020; 11 D.F. Peng (934_CR18) 2014; 5 H. Chen (934_CR11) 2020; 20 P. Jagust (934_CR10) 2020; 12 H. Sung (934_CR1) 2021; 71 S.-G. Ahn (934_CR28) 2005; 392 T. Ramming (934_CR7) 2014; 70 K.Y. Paik (934_CR15) 2008; 23 E. Batlle (934_CR5) 2017; 23 M. Shiota (934_CR16) 2010; 30 S. Daisy Precilla (934_CR23) 2022; 95 Z. Dastoor (934_CR27) 2000; 113 Y. He (934_CR25) 2021; 6 C.D. Fleming-de-moraes (934_CR24) 2022; 23 |
References_xml | – volume: 12 start-page: 1410 year: 2020 end-page: 1428 ident: CR10 article-title: Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells publication-title: World J. Stem. Cells doi: 10.4252/wjsc.v12.i11.1410 – volume: 113 start-page: 2845 issue: Pt 16 year: 2000 end-page: 2854 ident: CR27 article-title: Nuclear translocation and aggregate formation of heat shock cognate protein 70 (Hsc70) in oxidative stress and apoptosis publication-title: J. Cell Sci. doi: 10.1242/jcs.113.16.2845 – volume: 406 start-page: 503 year: 2011 end-page: 515 ident: CR6 article-title: Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2010.12.039 – ident: CR14 – volume: 11 start-page: 3299 year: 2020 end-page: 3308 ident: CR9 article-title: GPX8 promotes migration and invasion by regulating epithelial characteristics in non-small cell lung cancer publication-title: Thorac Cancer doi: 10.1111/1759-7714.13671 – volume: 48 start-page: 497 year: 2008 end-page: 507 ident: CR12 article-title: Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence publication-title: Hepatology doi: 10.1002/hep.22393 – volume: 20 start-page: 596 year: 2020 ident: CR11 article-title: GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway publication-title: Cancer Cell Int. doi: 10.1186/s12935-020-01692-z – volume: 23 start-page: 766 year: 2008 end-page: 770 ident: CR15 article-title: What prognostic factors are important for resected intrahepatic cholangiocarcinoma? publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2007.05040.x – volume: 23 start-page: 1 year: 2022 end-page: 13 ident: CR24 article-title: Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2022.2108690 – volume: 70 start-page: 106 year: 2014 end-page: 116 ident: CR7 article-title: GPx8 peroxidase prevents leakage of H2O2 from the endoplasmic reticulum publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2014.01.018 – volume: 5 start-page: 510 year: 2014 end-page: 517 ident: CR18 article-title: Glutathione peroxidase 7 suppresses bile salt-induced expression of pro-inflammatory cytokines in Barrett’s carcinogenesis publication-title: J. Cancer doi: 10.7150/jca.9215 – volume: 95 start-page: 110350 year: 2022 ident: CR23 article-title: Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion? publication-title: Cell Signal doi: 10.1016/j.cellsig.2022.110350 – volume: 402 start-page: 271 year: 2021 end-page: 287 ident: CR21 article-title: Emerging roles for non-selenium containing ER-resident glutathione peroxidases in cell signaling and disease publication-title: Biol. Chem. doi: 10.1515/hsz-2020-0286 – volume: 30 start-page: 491 year: 2010 end-page: 497 ident: CR16 article-title: Heat shock cognate protein 70 is essential for Akt signaling in endothelial function publication-title: Arteriosclerosis Thrombosis Vasc. Biol. doi: 10.1161/ATVBAHA.109.193631 – volume: 26 start-page: e921775 year: 2020 ident: CR20 article-title: Glutathione peroxidase 8 as aprognostic biomarker of gastric cancer: an analysis of the cancer genome atlas (TCGA) data publication-title: Med. Sci. Monit. doi: 10.12659/msm.921775 – volume: 68 start-page: 9167 year: 2008 end-page: 9175 ident: CR13 article-title: Association of autophagy defect with amalignant phenotype and poor prognosis of hepatocellular carcinoma publication-title: Cancer Res. doi: 10.1158/0008-5472.Can-08-1573 – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: CR1 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – ident: CR17 – volume: 117 start-page: 21420 year: 2020 end-page: 21431 ident: CR8 article-title: The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.2010275117 – volume: 58 start-page: 239 year: 2011 end-page: 244 ident: CR22 article-title: Wnt/β-catenin signaling regulates MAPK and Akt1 expression and growth of hepatocellular carcinoma cells publication-title: Neoplasma doi: 10.4149/neo_2011_03_239 – volume: 63 start-page: 540 year: 2014 end-page: 551 ident: CR19 article-title: Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma publication-title: Gut. doi: 10.1136/gutjnl-2013-304612 – volume: 392 start-page: 145 year: 2005 end-page: 152 ident: CR28 article-title: Heat-shock cognate 70 is required for the activation of heat-shock factor 1 in mammalian cells publication-title: Biochem. J. doi: 10.1042/BJ20050412 – volume: 23 start-page: 1124 year: 2017 end-page: 1134 ident: CR5 article-title: Cancer stem cells revisited publication-title: Nat. Med. doi: 10.1038/nm.4409 – volume: 2 start-page: 16018 year: 2016 ident: CR4 article-title: Hepatocellular carcinoma publication-title: Nat. Rev. Dis. Primers. doi: 10.1038/nrdp.2016.18 – volume: 136 start-page: 354 year: 2012 end-page: 374 ident: CR26 article-title: Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2012.08.014 – volume: 12 start-page: 216 year: 2023 end-page: 228 ident: CR2 article-title: Areview of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights publication-title: Hepatobiliary Surg. Nutr. doi: 10.21037/hbsn-22-469 – volume: 380 start-page: 1450 year: 2019 end-page: 1462 ident: CR3 article-title: Hepatocellular carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1713263 – volume: 6 start-page: 425 year: 2021 ident: CR25 article-title: Targeting PI3K/Akt signal transduction for cancer therapy publication-title: Signal Transduct. Target Ther. doi: 10.1038/s41392-021-00828-5 – volume: 380 start-page: 1450 year: 2019 ident: 934_CR3 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1713263 – volume: 23 start-page: 1 year: 2022 ident: 934_CR24 publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2022.2108690 – volume: 30 start-page: 491 year: 2010 ident: 934_CR16 publication-title: Arteriosclerosis Thrombosis Vasc. Biol. doi: 10.1161/ATVBAHA.109.193631 – volume: 392 start-page: 145 year: 2005 ident: 934_CR28 publication-title: Biochem. J. doi: 10.1042/BJ20050412 – volume: 23 start-page: 1124 year: 2017 ident: 934_CR5 publication-title: Nat. Med. doi: 10.1038/nm.4409 – volume: 23 start-page: 766 year: 2008 ident: 934_CR15 publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2007.05040.x – volume: 58 start-page: 239 year: 2011 ident: 934_CR22 publication-title: Neoplasma doi: 10.4149/neo_2011_03_239 – ident: 934_CR17 doi: 10.1093/carcin/bgu083 – volume: 136 start-page: 354 year: 2012 ident: 934_CR26 publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2012.08.014 – volume: 20 start-page: 596 year: 2020 ident: 934_CR11 publication-title: Cancer Cell Int. doi: 10.1186/s12935-020-01692-z – volume: 63 start-page: 540 year: 2014 ident: 934_CR19 publication-title: Gut. doi: 10.1136/gutjnl-2013-304612 – volume: 48 start-page: 497 year: 2008 ident: 934_CR12 publication-title: Hepatology doi: 10.1002/hep.22393 – volume: 68 start-page: 9167 year: 2008 ident: 934_CR13 publication-title: Cancer Res. doi: 10.1158/0008-5472.Can-08-1573 – volume: 11 start-page: 3299 year: 2020 ident: 934_CR9 publication-title: Thorac Cancer doi: 10.1111/1759-7714.13671 – ident: 934_CR14 doi: 10.1186/s12916-019-1341-6 – volume: 95 start-page: 110350 year: 2022 ident: 934_CR23 publication-title: Cell Signal doi: 10.1016/j.cellsig.2022.110350 – volume: 12 start-page: 216 year: 2023 ident: 934_CR2 publication-title: Hepatobiliary Surg. Nutr. doi: 10.21037/hbsn-22-469 – volume: 113 start-page: 2845 issue: Pt 16 year: 2000 ident: 934_CR27 publication-title: J. Cell Sci. doi: 10.1242/jcs.113.16.2845 – volume: 117 start-page: 21420 year: 2020 ident: 934_CR8 publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.2010275117 – volume: 406 start-page: 503 year: 2011 ident: 934_CR6 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2010.12.039 – volume: 2 start-page: 16018 year: 2016 ident: 934_CR4 publication-title: Nat. Rev. Dis. Primers. doi: 10.1038/nrdp.2016.18 – volume: 70 start-page: 106 year: 2014 ident: 934_CR7 publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2014.01.018 – volume: 12 start-page: 1410 year: 2020 ident: 934_CR10 publication-title: World J. Stem. Cells doi: 10.4252/wjsc.v12.i11.1410 – volume: 26 start-page: e921775 year: 2020 ident: 934_CR20 publication-title: Med. Sci. Monit. doi: 10.12659/msm.921775 – volume: 5 start-page: 510 year: 2014 ident: 934_CR18 publication-title: J. Cancer doi: 10.7150/jca.9215 – volume: 402 start-page: 271 year: 2021 ident: 934_CR21 publication-title: Biol. Chem. doi: 10.1515/hsz-2020-0286 – volume: 6 start-page: 425 year: 2021 ident: 934_CR25 publication-title: Signal Transduct. Target Ther. doi: 10.1038/s41392-021-00828-5 – volume: 71 start-page: 209 year: 2021 ident: 934_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 |
SSID | ssj0000461656 |
Score | 2.3484025 |
Snippet | Purpose
GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma... GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC)... PurposeGPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1391 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase AKT protein Animals Antitumor activity Biomedical and Life Sciences Biomedicine Cancer Research Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Cell Line, Tumor Cell migration Cell Movement - genetics Down-regulation Down-Regulation - genetics Endoplasmic reticulum Female Gene Expression Regulation, Neoplastic Glutathione Glutathione Peroxidase - genetics Glutathione Peroxidase - metabolism Heat shock proteins Hepatocellular carcinoma Hsc70 protein Humans Immunoprecipitation Kinases KLF4 protein Kruppel-Like Factor 4 Liver cancer Liver Neoplasms - genetics Liver Neoplasms - metabolism Liver Neoplasms - pathology Male Mass spectroscopy Mice Mice, Inbred BALB C Mice, Nude Middle Aged Neoplastic Stem Cells - metabolism Neoplastic Stem Cells - pathology Oct-4 protein Oncology Pathology Phosphorylation Pluripotency Protein arrays Protein transport Proteins Proto-Oncogene Proteins c-akt - metabolism Signal transduction Signal Transduction - genetics Therapeutic targets Transcriptomes Tumors |
Title | Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration |
URI | https://link.springer.com/article/10.1007/s13402-024-00934-w https://www.ncbi.nlm.nih.gov/pubmed/38607517 https://www.proquest.com/docview/3092848147 https://www.proquest.com/docview/3038441785 https://pubmed.ncbi.nlm.nih.gov/PMC11322209 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9NADLbYXSFxQbwJLNUgcYNIybzDrSr7EAjEgUqFS5TMTHZ7aIK6qVb779fOo1VZOHDJZZxJYntie8b-DPAucJ9VZcCFZCoTy5SbOEuqJC54YrwMSpquHdDXb_p8Lj8v1GIoCrsas93HI8nuT70rdhOSsmW5jCkMl_H1ARwpjN0pkWvOp9udFYIQ113bVs4Jow8d7KFa5u_T7FukO27m3WzJP45MO0t0-ggeDi4km_Yyfwz3Qv0E7vdNJW-ewq9PGFiv-xbzyHTWVOzs-8KyZc0u0fa0De3VU_Ipc9RHqG5WxUfWF0syJG83q2bNCN6ZfoKsqD1bLS96PXkG89OTH7PzeOigEDu0vC1ehdfOlB4D0cILlwptdVA6K2VVOox0guTSKc-90lXGQ6q100YSBhdSaSWew2Hd1OElsMw6rXAOYUorfWVs5tO0lLay2ghVuAjej1zMf_dAGfkOEpl4niPP847n-XUExyOj82HRXOUiyTih-0sTwdvtMKo78aWoQ7MhGmGpa5pVEbzo5bJ9nLAaHaAU77Z7EtsSEJT2_ki9vOwgtdPuxCnJIvgwCnf3Xv_-jFf_R_4aHvBO8Sh_8BgO2_UmvEGfpi0ncDQ9-_nlZAIHMz2bdAp9C0ty8FI |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCa6FMN2KbpX6z42DdhtM2Dr7d6CPpZmbTFgLRDsYtiS3OYQe0gdFPv3o_xIkLU77OKLaNkmKZOUyI8Anxy1SZE7XEiqUCGPqQqTqIjCjEbKcie4atoBXV7J0Q0fT8SkKwq777Pd-yPJ5k-9KnZj3GfLUh76MJyHD89gUwupxQA2h8Pxj_Fyb8WDiMumcSulHqUPXeyuXubpidZt0iNH83G-5F-Hpo0tOtuGrc6JJMNW6q9gw5Wv4XnbVvL3G_h5gqH1vG0yj2wnVUG-fp9oMi3JHVqfuvK79T79lBjfSaisZtkRacslCZLXi1k1Jx7g2f8GSVZaMpvetpryFm7OTq-PR2HXQyE0aHtrvDIrjcothqKZZSZmUksnZJLzIjcY6zhOuRGWWiGLhLpYSiMV9yhcSCUFeweDsirdLpBEGylwDqZyzW2hdGLjOOe60FIxkZkAPvdcTH-1UBnpChTZ8zxFnqcNz9OHAA56RqfdsrlPWZRQj-_PVQAfl8Oo8J4vWemqhadh2vdN0yKAnVYuy8cxLdEFivFuvSaxJYEH014fKad3Dah23Jw5RUkAX3rhrt7r35-x93_kH-DF6PryIr04v_q2Dy9po4Q-m_AABvV84Q7Rw6nz951C_wGS5_Ig |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9RADLagCMQFlXegwCBxg6jJvNNb1bKUV9UDK624RMk86B52Ui1ZVfx7xpN9dCkcuOQyziSxPbE9Y38GeOOorXzr4kJSXuW8pCqvCl_kDS2U5U5wldoBfT2VJ2P-aSImV6r4U7b76khyqGlAlKbQ719Yv78pfGMcM2cpzzEk5_nlTbjFsRo4avSYHq53WRBOXKYWrpQiXl90tpeVM3-fZts6XXM5r2dO_nF8mqzSaBfuLd1JcjjI_z7ccOEB3B4aTP56CN-PY5A9H9rNRwGQzpMPZxNNpoGcRzvUd7hvj4moxGBPodDNmgMyFE6SSN4vZt2cINQz_hBJEyyZTX8MOvMIxqP3345O8mU3hdxEK9zHK7PSqNbGoLSxzJRMaumErFruWxOjHscpN8JSK6SvqCulNFJxxOOKVFKwx7ATuuCeAqm0kSLOwVSrufVKV7YsW669loqJxmTwdsXF-mIAzag38MjI8zryvE48ry8z2Fsxul4uoJ81KyqKSP9cZfB6PRxVH_nSBNctkIZp7KCmRQZPBrmsH8e0jM5QGe_WWxJbEyCs9vZImJ4neO0ynT4VVQbvVsLdvNe_P-PZ_5G_gjtnx6P6y8fTz8_hLk06iGmFe7DTzxfuRXR1-vZl0ubfTc_1Bw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Downregulation+of+GPX8+in+hepatocellular+carcinoma%3A+impact+on+tumor+stemness+and+migration&rft.jtitle=Cellular+oncology+%28Dordrecht%29&rft.au=Tao%2C+Chen-Yang&rft.au=Wu%2C+Xiao-Ling&rft.au=Song%2C+Shu-Shu&rft.au=Tang%2C+Zheng&rft.date=2024-08-01&rft.issn=2211-3428&rft.eissn=2211-3436&rft.volume=47&rft.issue=4&rft.spage=1391&rft.epage=1403&rft_id=info:doi/10.1007%2Fs13402-024-00934-w&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13402_024_00934_w |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-3428&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-3428&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-3428&client=summon |